Literature DB >> 10426333

Relation of early and one-year outcome after acute myocardial infarction to systemic arterial blood pressure on admission.

M Jonas1, E Grossman, V Boyko, S Behar, H Hod, H Reicher-Reiss.   

Abstract

We evaluated whether elevated blood pressure (BP) levels with an acute myocardial infarction (AMI) affect the in-hospital course, short-term, and 1-year outcome. Data were derived from a nationwide survey of 2,212 consecutive patients with AMI. Patients were stratified into 3 groups according to admission BP levels: 1,320 patients had normal BP, 840 patients had high BP, and 52 patients had excessive BP. In-hospital (7 days) course, short-term (30 days), and 1-year outcome was compared between the groups. The 3 groups were similar with respect to age, but patients with excessive BP were more likely to be women and have a history of systemic hypertension and diabetes mellitus. The rate of thrombolytic therapy was similar among the 3 groups, but patients with excessively elevated BP were treated during hospitalization much more often with beta blockers, angiotensin-converting enzyme inhibitors, and diuretics. The incidence of stroke, transient ischemic attack, and bleeding complications were comparable in the 3 groups. In-hospital mortality was 5.0% , 4.0%, and 1.9% in the normal, high, and excessively elevated BP groups, respectively (p = 0.19). The short-term rehospitalization or mortality rate was similar among the 3 groups. The 1-year mortality rate was 12.3%, 14.1%, and 10.2% in the normal, high, and excessively elevated BP groups, respectively (p = 0.61). A multivariate logistic regression analysis yielded age, women, and Killip class > or = 2 as the only significant predictors of mortality during follow-up. Thus, with the current medical therapy, excessively elevated BP levels with AMI is not associated with a worse short-term or 1-year outcome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426333     DOI: 10.1016/s0002-9149(99)00227-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Paola Attanà; Claudio Picariello; Gian Franco Gensini
Journal:  Heart Vessels       Date:  2011-07-07       Impact factor: 2.037

2.  An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction.

Authors:  Harlan M Krumholz; Zhenqiu Lin; Elizabeth E Drye; Mayur M Desai; Lein F Han; Michael T Rapp; Jennifer A Mattera; Sharon-Lise T Normand
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-03

3.  The impact of hypertension on patients with acute coronary syndromes.

Authors:  Claudio Picariello; Chiara Lazzeri; Paola Attanà; Marco Chiostri; Gian Franco Gensini; Serafina Valente
Journal:  Int J Hypertens       Date:  2011-06-22       Impact factor: 2.420

4.  Clinical characteristics and short-term outcomes in patients with elevated admission systolic blood pressure after acute ST-elevation myocardial infarction: a population-based study.

Authors:  Bi Huang; Yanmin Yang; Jun Zhu; Yan Liang; Huiqiong Tan
Journal:  BMJ Open       Date:  2014-06-13       Impact factor: 2.692

5.  Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.

Authors:  Núria Ribas; Cosme García-García; Oona Meroño; Lluís Recasens; Silvia Pérez-Fernández; Víctor Bazán; Neus Salvatella; Julio Martí-Almor; Jordi Bruguera; Roberto Elosua
Journal:  BMC Cardiovasc Disord       Date:  2017-02-07       Impact factor: 2.298

6.  Impact of Admission Systolic Blood Pressure and Antecedent Hypertension on Short-Term Outcomes After ST-Segment Elevation Myocardial Infarction: Strobe-Compliant Article.

Authors:  Wenfang Ma; Yan Liang; Jun Zhu; Yanmin Yang; Huiqiong Tan; Litian Yu; Xin Gao; Guangxun Feng; Jiandong Li
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.